AN AMERICAN BRAIN TUMOR CONSORTIUM (ABTC) PHASE I TRIAL OF ABT-888 (VELIPARIB), TEMOZOLOMIDE (TMZ), AND CONCURRENT RADIOTHERAPY (RT) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): HEMATOLOGIC TOXICITY IS LIMITING.

被引：0
|
作者：
Kleinberg, Lawrence [1 ]
Blakeley, Jaishri [1 ]
Mikkelsen, Tom [2 ]
Stevens, Glenn [3 ]
Ye, Xiaobu [1 ]
Ryu, Sam [2 ]
Desideri, Serena [1 ]
Desai, Bhardwaj [4 ]
Giranda, Vincent [4 ]
Grossman, Stuart [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[4] Abbott Labs, Chicago, IL USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 36 条
  • [1] An American Brain Tumor Consortium (ABTC) Phase 1 Trial of Veliparib (ABT-888), Temozolomide (TMZ), and Concurrent Radiation Therapy (RT) for Newly Diagnosed Glioblastoma Multiforme (GBM): Need for Modification to Approach for Combining These Therapies
    Kleinberg, L. R.
    Blakeley, J.
    Mikkelsen, T.
    Stevens, G.
    Ye, X.
    Ryu, S.
    Desideri, S.
    Desai, B.
    Giranda, V.
    Grossman, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S7 - S8
  • [2] Phase I adult brain tumor consortium (ARTC) trial of ABT-888 (veliparib), temozolomide (TMZ), and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM) including pharmacokinetic (PK) data
    Kleinberg, Lawrence
    Supko, Jeffrey G.
    Mikkelsen, Tom
    Blakeley, Jaishri O'Neill
    Stevens, Glen
    Ye, Xiaobu
    Desideri, Serena
    Ryu, Samuel
    Desai, Bhardwaj
    Giranda, Vincent L.
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] PSEUDOPROGRESSION (PSPR) AFTER CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Clarke, Jennifer
    Abrey, Lauren
    Karimi, Sasan
    Lassman, Andrew
    NEURO-ONCOLOGY, 2008, 10 (05) : 893 - 893
  • [4] Pseudoprogression (PsPr) after concurrent radiotherapy (RT) and temozolomide (TMZ) for newly diagnosed glioblastoma multiforme (GBM)
    Clarke, J. L.
    Abrey, L. E.
    Karimi, S.
    Lassman, A. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] PHASE 1 STUDY EVALUATING ABT-414 WITH CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Gan, H. K.
    Fichtel, L.
    Lassman, A.
    Merrell, R.
    van den Bent, M. J.
    Kumthekar, P.
    Scott, A.
    Pedersen, M.
    Gomez, E.
    Fischer, J.
    Ames, W.
    Xiong, H.
    Dudley, M.
    Roberts-Rapp, L.
    Ansell, P. J.
    Holen, K.
    Reardon, D. A.
    ANNALS OF ONCOLOGY, 2014, 25
  • [6] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [7] A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study
    Baxter, Patricia A.
    Su, Jack M.
    Onar-Thomas, Arzu
    Billups, Catherine A.
    Li, Xiao-Nan
    Poussaint, Tina Young
    Smith, Edward R.
    Thompson, Patrick
    Adesina, Adekunle
    Ansell, Pete
    Giranda, Vincent
    Paulino, Arnold
    Kilburn, Lindsey
    Quaddoumi, Ibrahim
    Broniscer, Alberto
    Blaney, Susan M.
    Dunkel, Ira J.
    Fouladi, Maryam
    NEURO-ONCOLOGY, 2020, 22 (06) : 875 - 885
  • [8] A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report
    Su, Jack M.
    Thompson, Patrick
    Adesina, Adekunle
    Li, Xiao-Nan
    Kilburn, Lindsay
    Onar-Thomas, Arzu
    Kocak, Mehmet
    Chyla, Brenda
    McKeegan, Evelyn
    Warren, Katherine E.
    Goldman, Stewart
    Pollack, Ian F.
    Fouladi, Maryam
    Chen, Alice
    Giranda, Vincent
    Boyett, James
    Kun, Larry
    Blaney, Susan M.
    NEURO-ONCOLOGY, 2014, 16 (12) : 1661 - 1668
  • [9] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Thomas, Alissa A.
    Beal, Kathryn
    McNeill, Katharine Anne
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Perez, Julio Arevalo
    Yamada, Yoshiya
    Anderson, Barry Douglas
    Lamson, Michael
    Burch, Brandon
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Omuro, Antonio Marcilio Padula
    Beal, Kathryn
    McNeill, Katharine Anne
    Thomas, Alissa A.
    Lin, Xuling
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Yamada, Yoshiya
    Gorman, Greg
    Lamson, Michael
    Bavisotto, Linda M.
    Karmali, Rashida A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
1234